$PDPR 0012 chart ready, #CBD product launch

New Post Public Reply Private Reply Replies (0) Message Board
TradeForProfits
113
$PDPR 0012 chart ready, #CBD product launch news:

https://finance.yahoo.com/news/marathon-group...00040.html

Marathon Group's Wholly Owned Subsidiary, MarathonRx, Secures 1st Large Order; 3 Product Lines Now Available
GlobeNewswire•March 11, 2019
WATERBURY, CT, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Marathon Group Corp. (PDPR) (the “Company” or “Marathon”) wholly owned subsidiary, MarathonRx, has signed their 1st order and expands product line to include previously mentioned 1,500mg Nano-Pure Ultra CBD Drops along with new products Tasty Drops 4 Pets and Muscle & Joint Salve.

MarathonRx reviewed many companies to secure top quality products for their clients. Pure Health Product LLC, owned by Canbiola, Inc. (CANB), was chosen because they maintain a high level of quality throughout the manufacturing process, use organic ingredients wherever possible and/or naturally derived ingredients otherwise. Their manufacturing center is an all in one development laboratory and a fully integrated production facility whereby all formulations, processes, and materials are vertically integrated in the production process. To insure 100% quality control and product purity, once our raw materials have been received and individually tested for quality and purity all facets of our proprietary production processes are controlled in-house.

US Hemp industry just received a massive boost as sweeping change is enacted thanks to the passage and signing of the 2018 Farm Bill by President Trump. As a result, it is now legal to cultivate Hemp in the USA. This has opened the doors to a significant boost in CBD store fronts, both brick and mortar, as well as online. The CBD market is expected to reach over $2B in the next year according to various analysts, with some looking at a 10 fold increase by 2022 (the Brightfield Group).

1,500mg Nano-Pure Ultra CBD Drops: Made with pure hemp extract, Organic coconut oil and medium-chain-triglyceride (MCT)’s for maximum absorption and fast acting relief for a wide variety of health issues. MarathonRx nano cannabinoid delivery system delivers over 450% more CBD action per milligram than using hemp by itself. Why? This is due to the extremely small particle size in MarathonRx nano-drops and sprays combined with superior formulation of pure hemp extract and all-natural ingredients.

Tasty Drops 4 Pets is a special blend of hemp oil for dogs. This hemp oil food supplement was established to support and promote overall wellness of your pet. Each bottle of our hemp for dogs contains a 250mg high-concentrate hemp oil. The drops are easily and accurately dispensed using the squeezable dropper top.

Muscle & Joint Salve gets to the pain like no other salve on the market! Packed with nourishing omega-3 enriched oil, non-alcoholic witch hazel for toning benefits, aloe for soothing, pure Cannabidiol extract (CBD) to restore and protect damaged areas, and L-Carnitine, which is a naturally occurring amino acid that significantly increases the hydration level when applied topically. Lightly preserved with leuconostoc - which is commonly called Leucidal or radish root ferment, this preservative is EcoCert approved for certified organic formulas.

Mr. MacDonald Tudeme, CEO of Marathon, commented: “We are very pleased with the speed at which we've secured product and new client orders for MarathonRx. Sourcing of our products is very important and is why we chose Pure Health Product LLC (owned by Canbiola, Inc OTCQB: CANB) as our partner.”

You can stay up to date with our progress by visiting our website http://www.marathonrx.com and subscribing to our newsletter.

About Canbiola

Canbiola, Inc. (CANB) is a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. For more information about Canbiola, Inc., please visit: https://canbiola.com

About MarathonRx, Inc.

MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry. As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.

About Marathon Group Corp

Marathon Group Corp. (PDPR) is a Connecticut-based software company engaged in web property development, focused on solving problems faced by small and medium size businesses.

Safe Harbor Statement

The matters discussed, particularly information regarding future revenue, earnings, business plans and goals, consist of forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections and involve risks and uncertainties, which could cause actual results to differ materially from the forward-looking information. Such statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially. The Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking information contained herein is subject to the risk factors and uncertainties described in the Company’s filings with the Securities and Exchange Commission, which risk factors and uncertainties are incorporated by reference as though fully set forth herein.


Contact:

MacDonald Tudeme
jasmactt@gmail.com

Investor Relations:
Rage Marketing Inc.
info@ragemarketinginc.com
(800) 867-1851

Investors and Media:
IR@canbiola.com
(516) 595-9544

Hayden IR
hart@haydenir.com
(917) 658-7878
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 110

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 64

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 140

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 69

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 459

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading

Top 5 Most Recently Viewed Articles

3Srobotics Breaks Ground with North American Debut

Updated Category News Views 204

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

Continue Reading
Uganda Plans Major Spending Cuts and Reduced Borrowing for 2025

Updated Category News Views 912

Uganda's government announced a hefty shift in its fiscal playbook back in 2024, aiming to cut spending by over 20% and slash domestic borrowing by more than half for the upcoming 2025/26 fiscal year. This wasn’t just some routine budgetary tweak; it was a necessary maneuver amidst growing alarm about the nation's spiraling public debt. You know these moves grab...

Continue Reading
Vivos Therapeutics to Share Q1 2025 Results and Updates Soon

Updated Category News Views 257

Vivos Therapeutics Prepares for Q1 2025 Financial Disclosure Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering company in the medical devices sector, is gearing up to release its financial results for the first quarter of 2025. This announcement is anticipated to take place following the market's closure on a Thursday in May 2025. The management team is set to hold a...

Continue Reading
Join XBP Global for the Annual Turkey Trot This Thanksgiving

Updated Category News Views 217

XBP Global Welcomes You to the 11th Annual Turkey Trot XBP Global Holdings, Inc. (NASDAQ: XBP) is thrilled to invite the community to the 11th Annual Palisades Turkey Trot, a cherished tradition returning this Thanksgiving morning. Held at Palisades Green, this year's event promises excitement with new 5K and 10K courses that enhance the festive atmosphere of the...

Continue Reading
Market Reaction to CEO Departure and Boot Barn's Strong Quarter

Updated Category News Views 317

Boot Barn Stock Forecast Amid CEO Transition and Solid Performance In the latest developments regarding Boot Barn (NYSE: BOOT), analysts at Craig-Hallum have made notable adjustments to their stock price outlook. The price target has been revised to $160 from a previous $162, maintaining a Hold rating. The adjustments come in light of the company's impressive performance...

Continue Reading